ITGR vs TXG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Integer Holdings (ITGR) presents a dichotomy between strong forward-looking earnings potential and weak current market sentiment. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the stock is currently trading almost exactly at its growth-based intrinsic value of $85.26, leaving no margin of safety. While the trailing P/E is high, the Forward P/E of 11.71 and explosive YoY earnings growth of 52.9% suggest a significant valuation correction is underway. However, a bearish technical trend and negative insider sentiment temper the bullish analyst consensus.
TXG exhibits a stark divergence between its strong balance sheet liquidity and its poor operational health, evidenced by a weak Piotroski F-Score of 2/9. While the company maintains a very low Debt/Equity ratio (0.11) and a robust Current Ratio (4.46), revenue growth has stagnated at 0.60% YoY. The stock is currently trading at a significant premium with a Forward P/E of 114.85, despite negative profit margins. Recent price recovery is strong, but insider selling and bearish technical trends suggest caution.
Compare Another Pair
Related Comparisons
ITGR vs TXG: Head-to-Head Comparison
This page compares Integer Holdings Corporation (ITGR) and 10x Genomics, Inc. (TXG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.